Coston McIsaac & Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Hold |
170
| – | – | 0.01% | 425 |
|
|
2025
Q1 | $18K | Buy |
170
+20
| +13% | +$2.12K | 0.01% | 407 |
|
|
2024
Q4 | $14K | Hold |
150
| – | – | ﹤0.01% | 445 |
|
|
2024
Q3 | $17 | Hold |
150
| – | – | ﹤0.01% | 418 |
|
|
2024
Q2 | $15K | Hold |
150
| – | – | ﹤0.01% | 419 |
|
|
2024
Q1 | $14K | Hold |
150
| – | – | ﹤0.01% | 438 |
|
|
2023
Q4 | $15K | Hold |
150
| – | – | 0.01% | 428 |
|
|
2023
Q3 | $15K | Hold |
150
| – | – | 0.01% | 416 |
|
|
2023
Q2 | $15K | Hold |
150
| – | – | 0.01% | 448 |
|
|
2023
Q1 | $13K | Hold |
150
| – | – | ﹤0.01% | 464 |
|
|
2022
Q4 | $13 | Buy |
150
+100
| +200% | +$9 | 0.01% | 473 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 567 |
|
|
2022
Q2 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 373 |
|